Table 4 Functional outcomes of the enrolled patients according to the follow up
FOLLOW UP | < 2 yrs | 2–5 yrs | > 5 yrs | ||||||
|---|---|---|---|---|---|---|---|---|---|
OUTCOMES SCORES | G A mean + SD (range) | G B mean + SD (range) | P value | G A mean + SD (range) | G B mean + SD (range) | P value | G A mean + SD (range) | G B mean + SD (range) | P value |
PASSIVE ROM(°) | |||||||||
 Anterior elevation | 168.4 + 25.6 (90–180) | 168.3 + 24.1 (110–180) | 0.8 | 172.1 + 17.6 (100–180) | 167 + 28.3 (90–180) | 0.98 | 171.3 + 20.3 (120–180) | 176.8 + 8.7 (140–180) | 0.84 |
 Extrarotation | 69.4 + 22.6 (30–90) | 72.1 + 20.1 (30–90) | 0.73 | 76.8 + 17.7 (30–90) | 70.4 + 23.5 (20–90) | 0.45 | 65.7 + 33 (0–90) | 83.3 + 20.1 (6–90) | 0.42 |
 Intrarotation | 86.3 + 10.5 (50–90) | 79.2 + 20.6 (30–90) | 0.54 | 80.5 + 17.5 (30–90) | 82.6 + 16.7 (30–90) | 0.43 | 84 + 19.9 (10–90) | 83.9 + 16.1 (30–90) | 0.98 |
ACTIVE ROM (°) | |||||||||
 Anterior elevation | 165.3 + 26.3 (90–180) | 163.3 + 29.2 (100–180) | 0.94 | 156.4 + 29.4 (90–180) | 165.3 + 26.7 (90–180) | 0.37 | 159.3 + 29 (90–180) | 170.1 + 21.9 (100–180) | 0.12 |
 Extrarotation | 43.4 + 13.2 (30–70) | 40.4 + 15.3 (15–70) | 0.73 | 47.5 + 19 (20–90) | 43.3 + 20.1 (0–90) | 0.59 | 41.6 + 16.3 (10–80) | 48.6 + 15.7 (15–90) | 0.26 |
STRENGHT (N) | |||||||||
 Anterior elevation | 49.98 + 25.48 (14.7–107.8) | 49 + 21.56 (19.6–83.3) | 0.8 | 38.22 + 20.58 (9.8–107.8) | 49 + 26.46 (19.6–107.8) | 0.27 | 39.2 + 13.72 (19.6–68.6) | 46.06 + 20.58 (19.6–107.8) | 0.4 |
 Extrarotation | 48.02 + 24.5 (14.7–102.9) | 49.98 + 21.56 (19.6–73.5) | 0.91 | 43.12 + 18.62 (16.66–102.9) | 50.96 + 21.56 (19.6–7.35) | 0.32 | 36.26 + 11.76 (19.6–58.8) | 47.04 + 19.6 (24.5–107.8) | 0.12 |
 Intrarotation | 69.58 + 29.4 (24.5–107.8) | 68.6 + 33.32 (9.8–107.8) | 0.98 | 60.76 + 23.52 (29.4–107.8) | 70.56 + 31.36 (29.4–107.8) | 0.48 | 62.72 + 19.6 (29.4–107.8) | 77.42 + 23.52 (39.2–11) | 0.35 |